- Home
- PMEC vs FBIO Comparison
PMEC vs FBIO Comparison
Compare PMEC & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- FBIO
- Stock Information
- Founded
- PMEC 1984
- FBIO 2006
- Country
- PMEC Singapore
- FBIO United States
- Employees
- PMEC N/A
- FBIO N/A
- Industry
- PMEC
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- FBIO Health Care
- Exchange
- PMEC Nasdaq
- FBIO Nasdaq
- Market Cap
- PMEC 46.1M
- FBIO 49.1M
- IPO Year
- PMEC 2023
- FBIO N/A
- Fundamental
- Price
- PMEC $1.39
- FBIO $1.86
- Analyst Decision
- PMEC
- FBIO Strong Buy
- Analyst Count
- PMEC 0
- FBIO 2
- Target Price
- PMEC N/A
- FBIO $21.00
- AVG Volume (30 Days)
- PMEC 61.6K
- FBIO 226.7K
- Earning Date
- PMEC 12-31-2024
- FBIO 08-12-2025
- Dividend Yield
- PMEC N/A
- FBIO N/A
- EPS Growth
- PMEC N/A
- FBIO N/A
- EPS
- PMEC N/A
- FBIO N/A
- Revenue
- PMEC $74,310,000.00
- FBIO $57,784,000.00
- Revenue This Year
- PMEC N/A
- FBIO $51.59
- Revenue Next Year
- PMEC N/A
- FBIO $44.74
- P/E Ratio
- PMEC N/A
- FBIO N/A
- Revenue Growth
- PMEC 3.94
- FBIO N/A
- 52 Week Low
- PMEC $0.49
- FBIO $1.33
- 52 Week High
- PMEC $1.46
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- PMEC 59.24
- FBIO 51.19
- Support Level
- PMEC $1.00
- FBIO $1.70
- Resistance Level
- PMEC $1.46
- FBIO $2.15
- Average True Range (ATR)
- PMEC 0.12
- FBIO 0.11
- MACD
- PMEC 0.02
- FBIO -0.02
- Stochastic Oscillator
- PMEC 67.32
- FBIO 33.33
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.